Clinical Trial Update: Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial [Phase 2, Phase 3]

View source ↗

Summary

Stanford University is recruiting for a Phase 2/3 clinical trial evaluating N-acetylcysteine for autism spectrum disorder, focusing on the neurobiology of repet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Stanford University | Conditions: Autism Spectrum Disorder | Phase 2, Phase 3 | Status: RECRUITING